Nuvellus

Rotational Fractional Resection Technology Moves One Step Closer To Approval

Rotational Fractional Resection

Recros Medica’s de novo regulatory submission for the Nuvellus Focal Contouring System has been accepted for review by the U.S. Food and Drug Administration (FDA). The device utilizes the company’s proprietary Rotational Fractional Resection (RFR) technology, which creates fractional wounding without heat or energy and may provide medical aesthetic physicians a minimally invasive single treatment option to improve submental contouring.